Paul Stockhammer Özlem Okumus Luca Hegedus Dominika Rittler Till Ploenes Thomas Herold Stavros Kalbourtzis Agnes Bankfalvi Antje Sucker Rainer Kimmig Clemens Aigner Balazs Hegedus
10.3389/pore.2021.636088
Pathol Oncol Res
2021 Mar 26;27:636088.
arid1a hdac inhibition epithelial-mesenchymal transition mesenchymal-epithelial transition targeted therapy uterine carcinosarcoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/34257602/
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Carcinosarcoma / pathology Cell Cycle Checkpoints Epithelial-Mesenchymal Transition Histone Deacetylases / chemistry Pleural Effusion, Malignant / pathology Uterine Neoplasms / pathology
Antineoplastic Combined Chemotherapy Protocols / therapeutic use Carcinosarcoma / pathology Cell Cycle Checkpoints Epithelial-Mesenchymal Transition Histone Deacetylases / chemistry Pleural Effusion, Malignant / pathology Uterine Neoplasms / pathology Case Reports Biomarkers, Tumor / genetics Carcinosarcoma / drug therapy Carcinosarcoma / metabolism Cisplatin / administration & dosage Female Gene Expression Regulation, Neoplastic Humans Middle Aged Mutation Paclitaxel / administration & dosage Phthalazines / administration & dosage Piperazines / administration & dosage Pleural Effusion, Malignant / drug therapy Pleural Effusion, Malignant / metabolism Prognosis Pyrazoles / administration & dosage Quinolines / administration & dosage Tumor Cells, Cultured Uterine Neoplasms / drug therapy Uterine Neoplasms / metabolism Vorinostat / administration & dosage Biomarkers, Tumor Phthalazines Piperazines Pyrazoles Quinolines Vorinostat LY-2157299 Histone Deacetylases Paclitaxel Cisplatin olaparib
PMC8262245
34257602
HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line
2021